M|A|R|K|E|T
Investment
International Oncology to get Rs 20 crores from RVCF
R
ajasthan Venture Capital Fund (RVCF) has invested Rs 20 crores in International Oncology Services Pvt Ltd (IOSPL), a super speciality cancer care company for an undisclosed equity stake. International Oncology has established comprehensive cancer care centres (known as International Oncology Centre) equipped with modern technology at Fortis Hospital, Noida and Dr L H Hiranandani Hospital, Mumbai. The company has marked several cities in India to set up cancer care centres to make cancer care more accessible to the masses. The next two centres are expected to open in Rajasthan and Punjab shortly. "The oncology sector is currently witnessing a huge gap in terms of incidence of cancer in the country and limited quality cancer care facilities to treat the same. While the incidence of cancer is increasing at an alarming rate in India; the country faces large limitations in terms of lack of technical specialisation and trained personnel. India has few public sector cancer centres, some central establishment and limited private sector participation. IOSPL, through its specialised cancer care centres, is set to address this burgeoning demand in India" said Rajendra Bhanawat, Chairman of RVCF. Pradeep K Jaisingh, CEO and MD of IOSPL said, "After setting up comprehensive cancer centres in NCR and Mumbai, we are in the process of taking world class cancer care to several other states of India and Rajasthan is a special focus area for us. This investment by RVCF will help IOSPL carry out its immediate expansion plans and we are delighted to have their support." . EH News Bureau
30
EXPRESS HEALTHCARE
TRAINING
Vasan Eye Care conducts CME training programme on oculoplasty Over 150 doctors and eye care practitioners participated in the CME Programme asan Eye Care Hospitals, in association with Bangalore Opthalmic Society (BOS), conducted a continuing medical education (CME) programme on 'Current Concept in Oculoplasty Procedures' under the guidance of National Faculty and BOS Faculty at the Vasan Eye Care Hospital, Bangalore. More than 150 eye care practitioners from various hospitals in and around Bangalore participated in the CME Programme. Dr Roshmi Gupta who established the first exclusive oculoplasty practice in
V
Bangalore in 2004 hosted the CME. The programme featured sessions by 'Padmasree' Dr Ashok Grover, former President, All India Ophthalmic Society, Dr Santosh Honavar, “Bhatnagar” award winner for his work on eye cancers and Dr Milind Naik, Vice-President Asia-Pacific Society for Ophthalmic Plastic and Reconstructive Surgery. Together, the doctors covered a range of topics including eyelid reconstructions, managing a contracted socket, current approach to thyroid eye disease, the rational approach to ptosis and much more.
Dr AM Arun, Chairman, Vasan Healthcare said, “Oculoplasty is one of the fastest evolving sub-specialities in opthalmology. New understanding of the ocular adnexal tissues leads to the shift is towards functional procedures, performed with attention to aesthetics, and aesthetics procedures, done with attention to function. We all want the best care for our patients; and increasingly, our patients know the best of what is available worldwide, and expect the best. We are happy to conduct the continued medical education programme on the ever-
DR ASHOK GROVER
widening scope of oculoplastic procedures.” Oculoplasty is a complex and rare case that needs super-specialised treatment. Oculoplasty deals with disease around the eye – the socket, eyelids and tear drainage. The defects can be by birth, caused by injury or by eye tumour. EH News Bureau
RESEARCH
Asian Heart Institute to research benefits of walking for corporate employees Stepathlon Lifestyle to partner AHI in this research sian Heart Institute (AHI), alongwith Stepathlon Lifestyle plans to conduct a research to understand the positive effects of walking and incidental activity on the risks of diabetes, heart disease, obesity and metabolic syndrome on corporate employees in India. Known as Stepathlon, the research would be an initiative which will provide a solution that transforms the sedentary into active and the active into more active, irrespective of age, gender, des-
A
ignation, location and fitness levels through a pedometerbased, mass participation programme conducted over 100 consecutive days. The first edition of Stepathlon will commence from September 10, 2012. Dr Ramakanta Panda, Vice Chairman and Managing Director, Asian Heart Institute said, “We are glad to associate with Stepathlon to bring out research which will track and study the positive effects of walking and physical activity on heart diseases
and Type-2 diabetes. Stepathlon is a simple activity which will help employees to work towards an activityfilled life, thus enabling them to live healthy and reduce their risks of life-threatening diseases.” As part of this research, Stepathlon participants from select corporations in India will be tested pre- and postStepathlon for changes in common risk factors for ailments such as heart-related diseases and Type-2 diabetes. These risk factors include cholesterol, triglycerides,
weight, waist circumference and fasting blood glucose. The research aims to correlate the number of steps taken in a day with changes in these risk factors. Stepathlon’s Wellness Grant Programme will support programmes that build awareness or education in these areas. The Grant will also fund research and development programs for prevention and cure of diseases related to sedentary lifestyles. EH News Bureau
Centre for Sight forays into Indore, MP It has a network of 41 super specialised eye hospitals across India entre for Sight, India’s leading eye hospital network now expands to Indore. With state-of-theart infrastructure and a team of distinguished doctors, Centre for Sight has now made world class eye care accessible to people of Indore. Eminent ophthalmologist of the town, Dr Prateep Vyas, has joined it as Medical
C
Director, Centre for Sight Indore, along with leading Cornea & Refractive Surgeon, Dr Sharadini Vyas. On the expansion plan Dr Mahipal Sachdev, Chairman & Medical Director, Centre for Sight informed, “This is our maiden venture in Madhya Pradesh and by 2012 we plan to expand to six centres in Bhopal, Jabalpur, Gwalior, www.expresshealthcare.in
Ujjain and Rewa.” In its new facility of Indore, Centre for Sight has introduced technology like micro incision cataract surgery (MICS) and femtosecond bladefree LASIK surgery for refractive surgery (vision correction procedure to remove spectacles). In addition, Centre for Sight, Indore has a state-of-the-art Retina
Institute headed by Dr Teena Agarwal, eminent retina specialist trained at Sankara Nethralaya, Chennai. Equipped with the latest technology it provides comprehensive management of both medical and surgical diseases that affect the retina and vitreous. EH News Bureau AUGUST 2012